The German biotechnology company BionTech reduced net profit 1.8 times in the fourth quarter of 2024, but its income was more than the expectations of analysts. In October-December, the net profit of the company decreased to 259.5 million euros, or 1.08 euros per rally, 457.9 million euros, or 1,88 in one action, ...